Related Experiment Video
Updated: Jul 18, 2026
03:08
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Metabolic control analysis to identify optimal drug targets
Jorrit J Hornberg1, Frank J Bruggeman, Barbara M Bakker
1Department of Molecular Cell Physiology, Institute for Molecular Cell Biology, Faculty of Earth and Life Sciences, Vrije Universiteit, Amsterdam, The Netherlands. jorrit.hornberg@organon.com
Summary
Metabolic Control Analysis (MCA) quantifies how individual metabolic steps impact system function. This method identifies rate-limiting enzymes and vulnerable pathogen pathways for targeted inhibition.
Area of Science:
- Systems biology
- Biochemistry
- Metabolic pathway analysis
Background:
- Metabolic pathways are crucial for cellular function.
- Understanding enzyme contributions is key to metabolic research.
- Quantitative methods are needed to analyze metabolic control.
Purpose of the Study:
- To describe the fundamental principles of Metabolic Control Analysis (MCA).
- To explain how MCA quantifies the control exerted by individual metabolic steps.
- To illustrate the application of MCA in identifying therapeutic targets.
Main Methods:
- Quantification of flux control using control coefficients.
- Measurement of step perturbation via elasticity coefficients.
- Application of response coefficients to assess pathway dynamics.
- Differential control analysis for comparing pathogen and host pathways.
Main Results:
- MCA provides a quantitative framework to assess enzyme importance in metabolic pathways.
- Control coefficients identify rate-limiting steps.
- Elasticity and response coefficients elucidate pathway behavior under perturbation.
- Differential control analysis successfully identified uniquely vulnerable steps in pathogen pathways.
Conclusions:
- Metabolic Control Analysis is a powerful tool for understanding metabolic system regulation.
- MCA can identify specific enzyme targets for therapeutic intervention, particularly in pathogens.
- The methodology has broad applicability, demonstrated in glycolysis and oncogenic signaling.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...